{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:09:26Z","timestamp":1761894566919,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2778,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.bbmt.2007.05.011","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T07:24:06Z","timestamp":1185002646000},"page":"1041-1048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Extended Mycophenolate Mofetil and Shortened Cyclosporine Failed to Reduce Graft-versus-Host Disease after Unrelated Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning"],"prefix":"10.1016","volume":"13","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Baron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry E.","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Maris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia A.","family":"Langston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thoralf","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Bethge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Maziarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"McSweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Chauncey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"Shizuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed L.","family":"Sorror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann E.","family":"Woolfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.05.011_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbmt.2003.12.002","article-title":"Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants","volume":"10","author":"Hallemeier","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.05.011_bib2","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2003-03-0855","article-title":"Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years","volume":"102","author":"Wong","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0301-472X(00)00655-X","article-title":"Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation","volume":"29","author":"Nagler","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2007.05.011_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","article-title":"Limiting transplantation-related mortality following unrelated donor stem cell transplantion by using a nonmyeloablative conditioning regimen","volume":"99","author":"Chakraverty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","article-title":"HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies","volume":"102","author":"Maris","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib6","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib8","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","article-title":"Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects","volume":"97","author":"McSweeney","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","article-title":"Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning","volume":"23","author":"Baron","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.05.011_bib10","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation","volume":"89","author":"Storb","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib11","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"Niederwieser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbmt.2004.12.326","article-title":"HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia","volume":"11","author":"Baron","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.05.011_bib13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.leu.2403718","article-title":"High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation","volume":"19","author":"Baron","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.05.011_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2005.12.030","article-title":"Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing","volume":"12","author":"Maris","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.05.011_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/339625a0","article-title":"Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes","volume":"339","author":"Shi","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2007.05.011_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/9536","article-title":"Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2007.05.011_bib17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/15256","article-title":"Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance","volume":"5","author":"Li","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2007.05.011_bib18","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/blood-2002-10-3014","article-title":"The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade","volume":"101","author":"Blaha","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/77489","article-title":"Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo","volume":"6","author":"Chapuis","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2007.05.011_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00007890-200101150-00019","article-title":"Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment","volume":"71","author":"Izeradjene","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.05.011_bib21","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"635","article-title":"Graft-vs.-host disease","author":"Sullivan","year":"2004"},{"key":"10.1016\/j.bbmt.2007.05.011_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood.V100.1.48","article-title":"Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone","volume":"100","author":"Koc","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","article-title":"Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study","volume":"8","author":"Junghanss","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.05.011_bib24","doi-asserted-by":"crossref","first-page":"57a","DOI":"10.1182\/blood.V104.11.186.186","article-title":"Conversion of low donor chimerism following nonmyeloablative conditioning for hematopoietic cell transplantation (HCT) using pentostatin and donor lymphocyte infusion (DLI)","volume":"104","author":"Sandmaier","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib25","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2004-04-1506","article-title":"Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"104","author":"Baron","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib26","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/sj.leu.2404335","article-title":"Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning","volume":"20","author":"Baron","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.05.011_bib27","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.moh.0000177830.63033.9d","article-title":"Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning","volume":"12","author":"Baron","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2007.05.011_bib29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.tp.0000203556.06145.5b","article-title":"Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation","volume":"81","author":"Burroughs","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.05.011_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib31","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2004-06-2387","article-title":"Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT","volume":"105","author":"Crawley","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib32","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2006.06.9914","article-title":"Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopietic cell transplantation","volume":"24","author":"Baron","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.05.011_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2141.2005.05458.x","article-title":"Prognostic relevance of \u201cearly-onset\u201d graft-versus-host disease following nonmyeloablative hematopoietic cell transplantation","volume":"129","author":"Mielcarek","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.05.011_bib35","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2004-04-1473","article-title":"Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose","volume":"105","author":"Cao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.05.011_bib36","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/cncr.21418","article-title":"Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment","volume":"104","author":"Blaise","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2007.05.011_bib37","first-page":"2254","article-title":"Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients","volume":"7","author":"Bornhauser","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2007.05.011_bib38","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1182\/blood.V98.13.3868","article-title":"Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial","volume":"98","author":"Kansu","year":"2001","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107002996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107002996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:23Z","timestamp":1761057023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107002996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1083879107002996"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.05.011","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended Mycophenolate Mofetil and Shortened Cyclosporine Failed to Reduce Graft-versus-Host Disease after Unrelated Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}